Cargando…

Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers

Neoadjuvant chemotherapy (NACT) is frequently used in patients with early breast cancer. Randomized controlled trials have demonstrated similar survival after NACT or adjuvant chemotherapy (ACT). However, certain subtypes may benefit more when NACT contains regimes leading to high rates of pathologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortmann, O., Blohmer, J.-U., Sibert, N. T., Brucker, S., Janni, W., Wöckel, A., Scharl, A., Dieng, S., Ferencz, J., Inwald, E. C., Wesselmann, S., Kowalski, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article – Clinical Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984341/ https://www.ncbi.nlm.nih.gov/pubmed/35380257 http://dx.doi.org/10.1007/s00432-022-03938-x

Ejemplares similares

Use of social service counseling by cancer patients: an analysis of quality assurance data of 6339 breast cancer patients from 13 certified centers in Germany treated between 2015 and 2017
por: Breidenbach, Clara, et al.
Publicado: (2021)

miR-638 Serves as a Biomarker of 5-Fluorouracil Sensitivity to Neoadjuvant Chemotherapy in Breast Cancer
por: Wang, Bin, et al.
Publicado: (2022)

Downregulation of miR-638 promotes progression of breast cancer and is associated with prognosis of breast cancer patients
por: Li, Minghong, et al.
Publicado: (2018)

Could existing infrastructure for using patient‐reported outcomes as quality measures also be used for individual care in patients with colorectal cancer?
por: Breidenbach, Clara, et al.
Publicado: (2021)

Clinicians’ knowledge and attitudes towards patient reported outcomes in colorectal cancer care – insights from qualitative interviews
por: Sibert, Nora Tabea, et al.
Publicado: (2021)

Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society
por: Kowalski, Christoph, et al.
Publicado: (2017)

CREB1/Lin28/miR-638/VASP Interactive Network Drives the Development of Breast Cancer
por: Hu, Peng-Chao, et al.
Publicado: (2019)

Role of Renin-Angiotensin-System in Human Breast Cancer Cells: Is There a Difference in Regulation of Angiogenesis between Hormone-Receptor Positive and Negative Breast Cancer Cells?
por: Herr, Daniel, et al.
Publicado: (2019)

Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?
por: Hatzipanagiotou, Maria Eleni, et al.
Publicado: (2023)

Barriers and Facilitating Factors for Research Involvement in Cancer Centers: A Survey of Colorectal Cancer Center Coordinators in Germany, Austria, and Switzerland
por: Kowalski, Christoph, et al.
Publicado: (2018)

Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro
por: Schüler-Toprak, Susanne, et al.
Publicado: (2016)

Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
por: Inwald, E. C., et al.
Publicado: (2013)

Different Approaches for Case-Mix Adjustment of Patient-Reported Outcomes to Compare Healthcare Providers—Methodological Results of a Systematic Review
por: Sibert, Nora Tabea, et al.
Publicado: (2021)

Update Breast Cancer 2018 (Part 1) – Primary Breast Cancer and Biomarkers
por: Taran, Florin-Andrei, et al.
Publicado: (2018)

MicroRNA-638 inhibits the progression of breast cancer through targeting HOXA9 and suppressing Wnt/β-cadherin pathway
por: Xu, Qian, et al.
Publicado: (2021)

Guideline-concordant chemotherapy in patients with hormone receptor-positive and node-positive, early breast cancer leads to better overall and metastases-free survival with limited benefit in elderly patients
por: Taubenhansl, Clara, et al.
Publicado: (2019)

Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival?
por: Ebner, Florian, et al.
Publicado: (2019)

Guideline Concordant Therapy Prolongs Survival in HER2-Positive Breast Cancer Patients: Results from a Large Population-Based Cohort of a Cancer Registry
por: Inwald, E. C., et al.
Publicado: (2014)

Update Breast Cancer 2019 Part 4 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast Cancer
por: Schütz, Florian, et al.
Publicado: (2019)

Update Breast Cancer 2018 (Part 2) – Advanced Breast Cancer, Quality of Life and Prevention
por: Schneeweiss, Andreas, et al.
Publicado: (2018)

Update Breast Cancer 2019 Part 5 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer
por: Welslau, Manfred, et al.
Publicado: (2019)

To clip or not to clip the breast tumor bed? A retrospective look at the geographic miss index and normal tissue index of 110 patients with breast cancer
por: Ebner, Florian, et al.
Publicado: (2017)

miR-638 mediated regulation of BRCA1affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer
por: Tan, Xiaohui, et al.
Publicado: (2014)

Meeting patients’ health information needs in breast cancer center hospitals – a multilevel analysis
por: Kowalski, Christoph, et al.
Publicado: (2014)

AGO Algorithms for the Treatment of Breast Cancer: Update 2021
por: Schneeweiss, Andreas, et al.
Publicado: (2021)

4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival
por: Inwald, Elisabeth Christine, et al.
Publicado: (2015)

Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score
por: Ebner, Florian, et al.
Publicado: (2023)

MiR-638 acts as a tumor suppressor gene in gastric cancer
por: Shen, Yu, et al.
Publicado: (2017)

Update Breast Cancer 2019 Part 3 – Current Developments in Early Breast Cancer: Review and Critical Assessment by an International Expert Panel
por: Kolberg, Hans-Christian, et al.
Publicado: (2019)

Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology
por: Inwald, EC, et al.
Publicado: (2017)

Update Breast Cancer 2020 Part 4 – Advanced Breast Cancer
por: Tesch, Hans, et al.
Publicado: (2020)

Update Breast Cancer 2018 (Part 4) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Treatment Strategies for Advanced Breast Cancer
por: Müller, Volkmar, et al.
Publicado: (2018)

Comprehensive analysis reveals GRP94 is associated with worse prognosis of breast cancer
por: Wang, Ting, et al.
Publicado: (2021)

Update Breast Cancer 2020 Part 3 – Early Breast Cancer
por: Huober, Jens, et al.
Publicado: (2020)

Update Breast Cancer 2018 (Part 3) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer
por: Wöckel, Achim, et al.
Publicado: (2018)

Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer
por: Diessner, Joachim, et al.
Publicado: (2016)

MON-638 The WBC Differential in Relation to DKA Severity
por: Alamri, Bader Nasser, et al.
Publicado: (2020)

Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis
por: Hu, Lixia, et al.
Publicado: (2021)

Awareness, offer, and use of psychosocial services by breast cancer survivors in Germany: a prospective multi-centre study
por: Singer, Susanne, et al.
Publicado: (2022)

The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients
por: Stein, Roland Gregor, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k3piqhlu2gu8dnhinee5i4d1oi